Calcium treatment for premenstrual syndrome

Citation
Mw. Ward et Td. Holimon, Calcium treatment for premenstrual syndrome, ANN PHARMAC, 33(12), 1999, pp. 1356-1358
Citations number
10
Categorie Soggetti
Pharmacology
Journal title
ANNALS OF PHARMACOTHERAPY
ISSN journal
10600280 → ACNP
Volume
33
Issue
12
Year of publication
1999
Pages
1356 - 1358
Database
ISI
SICI code
1060-0280(199912)33:12<1356:CTFPS>2.0.ZU;2-2
Abstract
OBJECTIVE: To evaluate the use of calcium supplementation in the treatment of premenstrual syndrome. DATA SOURCES: Clinical literature accessed through MEDLINE (from January 19 67 to September 1999). Key search terms included calcium PMS, and premenstr ual. DATA SYNTHESIS: UP to 50% of women experience some form of premenstrual syn drome. An evaluation of studies focusing on calcium in the management of pr emenstrual symptoms was conducted. CONCLUSIONS: Calcium supplementation of 1201-1600 mg/d, unless contraindica ted, should be considered a sound treatment option in women who experience premenstrual syndrome. The supplemental dose of calcium can be adjusted dow nward in the few patients who routinely consume large quantities of calcium in their diet.